Regulatory woes in Washington, including over China Zhongwang's deal for Aleris, are raising questions over whether Chinese buyers will be put off M&A in the USA
Donald Trump's delay in appointing key officials is already slowing down the approval process for M&A deals in the US – even before any policy changes kick in.